
ALL
Allstate Corp
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
208.290
Open
207.090
VWAP
206.54
Vol
843.84K
Mkt Cap
54.41B
Low
205.995
Amount
174.29M
EV/EBITDA(TTM)
8.55
Total Shares
263.92M
EV
63.49B
EV/OCF(TTM)
7.26
P/S(TTM)
0.84
The Allstate Corporation protects people from life’s uncertainties with a wide array of protection for autos, homes, electronic devices and identity theft. The Company’s products are available through Allstate agents, independent agents, major retailers, online and at the workplace. Its Allstate Protection segment offers private passenger auto, homeowners, other personal lines and commercial insurance. Its Run-off Property-Liability segment includes property and casualty insurance coverage. The Company’s Protection Services segment provides consumer product protection plans, device and mobile data collection services and analytic solutions using automotive telematics information, roadside assistance, protection and insurance products and identity protection and restoration through Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside, Arity and Allstate Identity Protection.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
17.12B
+4.04%
6.451
+82.74%
17.32B
+4.91%
7.112
-7.28%
16.95B
+1.92%
4.699
+20.17%
Estimates Revision
The market is revising Upward the revenue expectations for The Allstate Corporation (ALL) for FY2025, with the revenue forecasts being adjusted by 0.69% over the past three months. During the same period, the stock price has changed by 1.98%.
Revenue Estimates for FY2025
Revise Upward

+0.69%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+2.29%
In Past 3 Month
Stock Price
Go Up

+1.98%
In Past 3 Month
15 Analyst Rating

12.13% Upside
Wall Street analysts forecast ALL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALL is 231.54 USD with a low forecast of 198.00 USD and a high forecast of 260.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Buy
1 Hold
1 Sell
Strong Buy

12.13% Upside
Current: 206.500

Low
198.00
Averages
231.54
High
260.00

12.13% Upside
Current: 206.500

Low
198.00
Averages
231.54
High
260.00
Keefe Bruyette
Meyer Shields
Outperform
maintain
$237 -> $246
2025-08-06
Reason
Keefe Bruyette
Meyer Shields
Price Target
$237 -> $246
2025-08-06
maintain
Outperform
Reason
Keefe Bruyette analyst Meyer Shields raised the firm's price target on Allstate to $246 from $237 and keeps an Outperform rating on the shares. Allstate's improved core loss ratio and declining rate increases should translate into personal auto PIF growth, driving earnings growth, the analyst tells investors in a research note.
Wells Fargo
Equal Weight
maintain
$197 -> $202
2025-08-05
Reason
Wells Fargo
Price Target
$197 -> $202
2025-08-05
maintain
Equal Weight
Reason
Wells Fargo raised the firm's price target on Allstate to $202 from $197 and keeps an Equal Weight rating on the shares. The firm notes Allstate shares responded better than it would have expected to earnings, as the market liked the strong margins. From here, Wells thinks upside will be driven off of their ability to show better PIF growth, which is still being hampered by declines in NY/NJ.
Raymond James
C. Gregory Peters
Strong Buy
maintain
$250 -> $260
2025-08-04
Reason
Raymond James
C. Gregory Peters
Price Target
$250 -> $260
2025-08-04
maintain
Strong Buy
Reason
Raymond James analyst C. Gregory Peters raised the firm's price target on Allstate to $260 from $250 and keeps a Strong Buy rating on the shares. The stock is up about 4% since its Q2 results came in ahead of estimates, reflecting better than expected underwriting profitability in home and auto, the analyst tells investors in a research note.
UBS
Buy
maintain
$230 -> $235
2025-07-09
Reason
UBS
Price Target
$230 -> $235
2025-07-09
maintain
Buy
Reason
UBS raised the firm's price target on Allstate to $235 from $230 and keeps a Buy rating on the shares. P&C Insurance stocks under coverage were down 4% in 2Q25, on average, reflecting less favorable fundamentals and a shift from defensive stocks to more economically sensitive stocks, the analyst tells investors in a research note. UBS favors Personal lines insurers into 2Q25 results where margins remain attractive.
Barclays
Underweight
maintain
$172 -> $188
2025-07-07
Reason
Barclays
Price Target
$172 -> $188
2025-07-07
maintain
Underweight
Reason
Barclays raised the firm's price target on Allstate to $188 from $172 and keeps an Underweight rating on the shares. Heading into Q2 earnings, the firm is more cautious on property and casualty carriers, saying underwriting margins face pressure from softening rates and unfavorable mix shift. Barclays is more constructive on reinsurers due to "idiosyncratic tailwinds" and capital return potential in the second half of the year. The analyst names Everest Group (EG) and Hartford Insurance (HIG) as top ideas.
BMO Capital
Outperform
maintain
$230
2025-05-16
Reason
BMO Capital
Price Target
$230
2025-05-16
maintain
Outperform
Reason
BMO Capital keeps an Outperform rating and $230 price target on Allstate but notes that the company's April policies-in-force, PIF, growth metric was shy of expectations considering seasonality. April is Progressive's (PGR) third-strongest PIF month, likely owing to tax refunds, the analyst tells investors in a research note, adding however that the firm expects organic policy count growth to beat expectations in the coming years.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Allstate Corp (ALL.N) is 9.37, compared to its 5-year average forward P/E of 1.75. For a more detailed relative valuation and DCF analysis to assess Allstate Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
1.75
Current PE
9.37
Overvalued PE
42.83
Undervalued PE
-39.33
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
2.79
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
7.78
Undervalued EV/EBITDA
-2.19
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
0.71
Current PS
0.79
Overvalued PS
0.82
Undervalued PS
0.60
Financials
Annual
Quarterly
FY2025Q2
YoY :
+5.85%
16.63B
Total Revenue
FY2025Q2
YoY :
+256.38%
1.93B
Operating Profit
FY2025Q2
YoY :
+504.90%
2.10B
Net Income after Tax
FY2025Q2
YoY :
+586.73%
7.76
EPS - Diluted
FY2025Q2
YoY :
-18.67%
1.87B
Free Cash Flow
FY2025Q2
YoY :
+24.28%
12.90
FCF Margin - %
FY2025Q2
YoY :
+471.04%
12.62
Net Margin - %
FY2025Q2
20.90
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
19.1M
USD
2
3-6
Months
36.7M
USD
4
6-9
Months
25.5M
USD
4
0-12
Months
13.4M
USD
2
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
417.4K
Volume
5
6-9
Months
703.9K
Volume
6
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
6
138.3K
Volume
Months
6-9
5
1.1M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
8.0K
USD
1
6-9
Months
0.0
USD
0
0-12
Months
32.0K
USD
4
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
19.1M
USD
2
3-6
Months
36.7M
USD
4
6-9
Months
25.5M
USD
4
0-12
Months
13.4M
USD
2
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ALL News & Events
Events Timeline
2025-07-30 (ET)
2025-07-30
17:52:18
Allstate reports Q2 adjusted EPS $5.94, consensus $3.26

2025-07-30
14:53:34
Notable companies reporting after market close

2025-07-17 (ET)
2025-07-17
08:17:11
Allstate announces estimated June catastrophe losses of $619M

Sign Up For More Events
Sign Up For More Events
News
4.0
08-11BenzingaJefferies Maintains Buy on Allstate, Raises Price Target to $255
4.0
08-06BenzingaKeefe, Bruyette & Woods Maintains Outperform on Allstate, Raises Price Target to $246
4.0
08-05Benzinga7 Analysts Assess Allstate: What You Need To Know
Sign Up For More News
People Also Watch

MSCI
MSCI Inc
549.390
USD
+0.50%

ROST
Ross Stores Inc
146.490
USD
+0.87%

PWR
Quanta Services Inc
384.120
USD
-0.53%

CHTR
Charter Communications Inc
258.770
USD
+0.86%

MPC
Marathon Petroleum Corp
158.590
USD
-1.40%

TRP
TC Energy Corp
49.970
USD
+1.22%

SU
Suncor Energy Inc
38.790
USD
-1.10%

PSX
Phillips 66
118.370
USD
-0.64%

OXY
Occidental Petroleum Corp
43.710
USD
-1.38%

MNST
Monster Beverage Corp
63.660
USD
-1.59%
FAQ

What is Allstate Corp (ALL) stock price today?
The current price of ALL is 206.5 USD — it has decreased -0.15 % in the last trading day.

What is Allstate Corp (ALL)'s business?

What is the price predicton of ALL Stock?

What is Allstate Corp (ALL)'s revenue for the last quarter?

What is Allstate Corp (ALL)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Allstate Corp (ALL)'s fundamentals?

How many employees does Allstate Corp (ALL). have?
